Richard Parkes analyst BNP

Currently out of the existing stock ratings of Richard Parkes, 3 are a BUY (50%), 2 are a HOLD (33.33%), 1 are a SELL (16.67%).

Richard Parkes

Work Performance Price Targets & Ratings Chart

Analyst Richard Parkes, currently employed at BNP, carries an average stock price target met ratio of 100% that have a potential upside of 22.41% achieved within 306 days. Previously, Richard Parkes worked at DEUTSCHE BANK.

Richard Parkes’s has documented 10 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on NVO, Novo Nordisk A/S at 02-Dec-2024.

Wall Street Analyst Richard Parkes

Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 6/27/2022. The price target of $52.88 was fulfilled within 1 day with a profit of $0.48 (0.9%) receiving and performance score of 9.

Average potential price target upside

AZN AstraZeneca PLC ADR NVO Novo Nordisk A/S NVS Novartis AG ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Dec-2019

$105

$-83.41 (-44.27%)

$95

7 months ago
(09-Dec-2025)

0/13 (0%)

$-72.77 (-40.93%)

Buy Since 05-Sep-2023

$108.5

$-79.91 (-42.41%)

$91.7

7 months 14 days ago
(25-Nov-2025)

1/6 (16.67%)

$-76.04 (-41.21%)

483

Hold Since 27-Oct-2025

8 months 12 days ago
(27-Oct-2025)

4/4 (100%)

$13.48 (10.43%)

88

Buy Since 30-May-2024

$97

1 years 3 months 9 days ago
(30-Mar-2025)

0/2 (0%)

$-43.8 (-31.11%)

Hold Since 12-Feb-2025

1 years 4 months 27 days ago
(12-Feb-2025)

6/6 (100%)

$29.07 (22.44%)

674

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Richard Parkes?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?